Quest Diagnostics on Dow Jones Sustainability World and North America indexes

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its seventh year on the World Index (since 2004) and in its sixth on the North American Index (since 2005).

The annual review is based on a thorough analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, branding, climate change mitigation, supply chain standards and labor practices. It accounts for general as well as industry specific sustainability criteria for each of 58 sectors defined according to the Industry Classification Benchmark.

"We are proud to be included in the Dow Jones Sustainability Index for the seventh consecutive year," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer of Quest Diagnostics. "This achievement highlights our commitment to the communities in which we live, our employees' health and well being, and protecting the environment."

The Dow Jones Sustainability Indexes (DJSI) track the financial performance of the leading sustainability-driven companies worldwide, providing asset managers with reliable and objective benchmarks. The DJSI World Index includes more than 300 companies, and the DJSI North America Index features approximately 100 companies selected from among the largest 600 North American corporations of the Dow Jones Global Total Stock Market Index. DJSI indexes are produced by Sustainable Asset Management Group (SAM), based in Zurich, Switzerland, together with Dow Jones Indexes and STOXX Limited. Additional information about the DJSI, including a list of all component companies, is available at: www.sustainability-indexes.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Quest Diagnostics. (2019, June 18). Quest Diagnostics on Dow Jones Sustainability World and North America indexes. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20100910/Quest-Diagnostics-on-Dow-Jones-Sustainability-World-and-North-America-indexes.aspx.

  • MLA

    Quest Diagnostics. "Quest Diagnostics on Dow Jones Sustainability World and North America indexes". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20100910/Quest-Diagnostics-on-Dow-Jones-Sustainability-World-and-North-America-indexes.aspx>.

  • Chicago

    Quest Diagnostics. "Quest Diagnostics on Dow Jones Sustainability World and North America indexes". News-Medical. https://www.news-medical.net/news/20100910/Quest-Diagnostics-on-Dow-Jones-Sustainability-World-and-North-America-indexes.aspx. (accessed April 25, 2024).

  • Harvard

    Quest Diagnostics. 2019. Quest Diagnostics on Dow Jones Sustainability World and North America indexes. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20100910/Quest-Diagnostics-on-Dow-Jones-Sustainability-World-and-North-America-indexes.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IBM, Quest Diagnostics launch new genomic tumor sequencing service to help advance precision medicine